📰 Belgian Transparency News
Page 2 - Belgian Transparency News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Belgian Transparency. Real-time updates on events, politics, business and more.
September 18, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – September 18, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a first transparency notification on September 14, 2023, from Atlas...
September 1, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – September 1, 2023 – 7.00 PM CET Oxurion NV , a biopharmaceutical company developing next generation standard of care ophthalmic therapies,...
August 23, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 23, 2023 – 8.00 PM CET Oxurion NV , a biopharmaceutical company developing next generation standard of care ophthalmic therapies,...
August 23, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 23, 2023 – 8.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
August 21, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 21, 2023 – 7.00 PM CET Oxurion NV , a biopharmaceutical company developing next generation standard of care ophthalmic therapies,...
August 7, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 7, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic...
July 17, 2023
PRESS RELEASE REGULATED INFORMATION ...
July 14, 2023
PRESS RELEASE REGULATED INFORMATION ...
July 5, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 5, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic...
June 23, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – June 23, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets ...